Literature DB >> 18156549

Leptospirosis pulmonary haemorrhage: a diagnostic challenge.

M Dall'Antonia1, G Sluga, S Whitfield, A Teall, P Wilson, D Krahé.   

Abstract

Leptospirosis is a re-emerging zoonosis with worldwide distribution. Antibiotic treatment is available, but leptospirosis is rarely suspected due to the non-specific clinical presentation, and is also underreported due to the difficulty in confirming the diagnosis. The syndrome of leptospirosis pulmonary haemorrhage is increasingly described; it is severe and can present without the classical manifestations of Weil's disease. We discuss two cases of leptospirosis with pulmonary haemorrhage; both our patients experienced a dramatic deterioration hours after their admission, and required emergency intubation and intensive therapy unit support. Massive haemoptysis is a life threatening complication of leptospirosis, even outside tropical areas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18156549     DOI: 10.1136/emj.2007.051524

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  4 in total

1.  A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations.

Authors:  Yvonne J Huang; Eugenia Kim; Michael J Cox; Eoin L Brodie; Ron Brown; Jeanine P Wiener-Kronish; Susan V Lynch
Journal:  OMICS       Date:  2010-02

2.  The farmer who didn't need a wheel barrow.

Authors:  Willibald Hochholzer; Christina Orasch; Stefanie Huber; Christian Arranto; Sabina Hunziker
Journal:  BMJ Case Rep       Date:  2009-06-01

3.  Pancreatitis and myocarditis followed by pulmonary hemorrhage, a rare presentation of leptospirosis- a case report and literature survey.

Authors:  Nuwan Ranawaka; Vijayabala Jeevagan; Panduka Karunanayake; Saroj Jayasinghe
Journal:  BMC Infect Dis       Date:  2013-01-24       Impact factor: 3.090

Review 4.  Pneumonia in the tropics.

Authors:  Tow Keang Lim; Wen Ting Siow
Journal:  Respirology       Date:  2017-08-01       Impact factor: 6.424

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.